Candidate target genes for loss of heterozygosity on human chromosome 17q21

L. DeMarchis, C. Cropp, Z. M. Sheng, S. Bargo, R. Callahan

Research output: Contribution to journalArticlepeer-review


Loss of heterozygosity (LOH) on chromosome 17q21 has been detected in 30% of primary human breast tumours. The smallest common region deleted occurred in an interval between the D17S746 and D17S846 polymorphic sequences tagged sites that are located on two recombinant PI-bacteriophage clones of chromosome 17q21: 122F4 and 50H1, respectively. To identify the target gene for LOH, we defined a map of this chromosomal region. We found the following genes: JUP, FK506BP10, SC65, Gastrin (GAS) and HAP1. Of the genes that have been identified in this study, only JUP is located between D17S746 and D17S846. This was of interest since earlier studies have shown that JUP expression is altered in breast, lung and thyroid tumours as well as cell lines having LOH in chromosome 17q21. However, no mutations were detected in JUP using single-strand conformation polymorphism analysis of primary breast tumour DNAs having LOH at 17q21. We could find no evidence that the transcription promoter for JUP is methylated in tumour DNAs having LOH at 17q21. We suspect that the target gene for LOH in primary human breast tumours on chromosome 17q21 is either JUP and results in a haploinsufficiency for expression or may be an unidentified gene located in the interval between D17S846 and JUP.

Original languageEnglish
Pages (from-to)2384-2389
Number of pages6
JournalBritish Journal of Cancer
Issue number12
Publication statusPublished - Jun 14 2004


  • Chromosome 17q21
  • Loss of heterozygosity
  • Plakoglobin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Candidate target genes for loss of heterozygosity on human chromosome 17q21'. Together they form a unique fingerprint.

Cite this